The Duke Comprehensive Cancer Center became one of the nation's first cancer centers in December 1971 after the passage of the National Cancer Act. In 1973, the Duke Cancer Center was designated a cancer center by the National Cancer Institute. Types of materials include correspondence, reports, reprinted articles, grant materials, photographs, brochures, meeting agendas, photographic contact sheets, and videotapes. Major themes include the External Scientific Review Committee, the Cancer Center Advisory Committee, Cancer Center support grants and core grants, Oncology Recreation Therapy, the Take-A-Seat Gala and Auction, and the Duke Center for Living. Materials range in date from 1943 to 2011.
Dr. O. Michael Colvin (1936-2013) served as director of the Duke Comprehensive Cancer Center from 1995 to 2002, and as William Shingleton Professor of Cancer Research from 2002 to 2008. In addition to his administrative and educative roles, Colvin conducted pioneering research on cyclophosphamide and other alkylating agents, in the pursuit of bettering chemotherapy and tumor treatment. Among other materials, the collection contains correspondence, clippings, committee and conference materials, research notes, writings, photographs, awards, and digital files. Major subjects include Colvin's research and positions in professional organizations. Materials range in date from 1957 to 2009, with the bulk dating from 1987 to 2009.
Dr. William W. Shingleton (1917-2005) was a Professor of Surgery at Duke University and the founding Director of the Duke Comprehensive Cancer Center. This collection contains 1 oral history interview conducted on January 13, 2004 by Jessica Roseberry. In this interview, Shingleton discusses his early career and the development of the Duke Comprehensive Cancer Center. He also discusses cancer research, surgery, and patient care.